"Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : http://offres.adocia.com/en
View Top Employees from ADOCIAWebsite | http://www.adocia.com |
Ticker | ADOC |
Revenue | $6.4 million |
Funding | $16.7 million |
Employees | 116 (116 on RocketReach) |
Founded | 2005 |
Address | 115 Avenue Lacassagne, Lyon, Wallis and Futuna 69003, FR |
Phone | +33 4 72 61 06 10 |
Fax | +33 4 72 36 39 67 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Alternative Medicine, Approved therapeutic proteins, Business Services, Health Care, Diabetes, Insulin Formulation, Drug delivery, Fast Insulin, Woun, Biotechnology, Science and Engineering, Therapeutics |
Web Rank | 5 Million |
Keywords | Adocia Action En Circulation, Adocia, Adocia Sa, Rapport Annuel Adocia, Adocia Preoces Lilly |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies |
Looking for a particular ADOCIA employee's phone or email?
The ADOCIA annual revenue was $6.4 million in 2024.
Gerard Soula is the Chairman of ADOCIA.
116 people are employed at ADOCIA.
ADOCIA is based in Lyon, Wallis and Futuna.
The NAICS codes for ADOCIA are [54171, 54, 5417, 541713, 541].
The SIC codes for ADOCIA are [873, 87].